Skip to main content

British Cancer Biobank Licenses Labvantage's Sapphire Software

NEW YORK (GenomeWeb News) — The British national cancer tissue bank OnCore has licensed Labvantage Solutions’ Sapphire software to help manage its biobank, the company said today.
 
Labvantage said OnCore will use the software to help track and manage biosamples and to function as a secure, flexible portal through which researchers can access the biobank.
 
OnCore, a joint project between England’s Department of Health, the Medical Research Council, the National Cancer Research Institute, and Cancer Research UK, was formed to provide quality tissue samples, anonymous patient information, and other aids to researchers seeking to treat or prevent cancer.
 
Financial terms of the deal were not released.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.